Citations

Clear

313 citation(s) found for "Alvarez, P".

Implementation of a virtual community of practice to promote the empowerment of middle-aged people with multimorbidity: study protocol of a randomised controlled trial
Campillejo, Alba , Larrondo, Ileana Gefaell , Ramos‐García, Vanesa , Koatz, Débora , Santos-Álvarez, Anthea, Barrio-Cortés, Jaime , Gómez-Rueda, Sara, Calderón‐Larrañaga, Amaia , Garrido-Elustondo, Sofía, León, Beatriz González de , Ramón-Vazquez, José, Martín, Candelaria , Súarez-Fernández, Carmen, Parra-Caballero, Pedro, Quiroga-Colina, Patricia, Ramírez‐Puerta, Ana Belén, Tello-Bernabé, María-Eugenia, Sanchez-Gamborino, Estrella, Ugalde-Abiega, Beatriz, Vall‐Roqué, Helena , Abt-Sacks, Analía , Hernández-Yumar, Aránzazu , Muth, Christiane , Akker, Marjan van den , Orrego, Carola , González‐González, Ana Isabel , van den Akker, Marjan , Orrego, Carola , González-González, Ana Isabel , García, Alba Campillejo , Cifuentes, Patricia, Coello, Santiago Domínguez , García-García, Francisco Javier, Parra, Pedro , Vicente‐Rabaneda, Esther F. , Ruíz-López, Marta, Tello-Bernabé, María Eugenia, Ugalde-Abiega, Beatriz , Duarte‐Díaz, Andrea , Sacks, Analía Abt , Torres‐Castaño, Alezandra , Álvarez‐Pérez, Yolanda , Montori, Víctor M. , Perestelo‐Pérez, Lilisbeth

Mayo Clinic

BMJ Open | May 24, 2024 | Volume: 14 | Issue: 5 | Pages: e084937

10.1136/bmjopen-2024-084937 | PMID 38803252 Get It

Introduction Empowering people living with multimorbidity (multiple chronic conditions) to gain greater confidence in managing their health can enhance their quality of life. Education focused on self-management is a key tool for fostering patient empowerment and is mostly provided on an individual basis. Virtual communities of practice (VCoP) present a unique opportunity for online education in chronic condition self-management within a social context. This research aims to evaluate the effectiveness/cost-effectiveness of individualised, online self-management education compared with VCoP among middle-aged individuals living with multiple chronic conditions. Methods and analysis People aged 30–60, living with ≥2 chronic conditions and receiving care in primary care (PC) centres and outpatient hospital-based clinics in Madrid and Canary Islands will enrol in an 18-month parallel-design, blinded (intervention assessment and data analysts), pragmatic (adhering to the intention-to-treat principle), individually randomised trial. The trial will compare two 12-month web-based educational offers of identical content; one delivered individually (control) and the other with online social interaction (VCoP, intervention). Using repeated measures mixed linear models, with the patient as random effect and allocation groups and time per group as fixed effects, we will estimate between-arm differences in the change in Patient Activation Measure from baseline to 12 months (primary endpoint), including measurements at 6-month and 18-month follow-up. Other outcomes will include measures of depression and anxiety, treatment burden, quality of life. In addition to a process evaluation of the VCoP, we will conduct an economic evaluation estimating the relative cost-effectiveness of the VCoP from the perspectives of both the National Health System and the Community. Ethics and dissemination The trial was approved by Clinical Research Ethics Committees of Gregorio Marañón University Hospital in Madrid/Nuestra Señora Candelaria University Hospital in Santa Cruz de Tenerife. The results will be disseminated through workshops, policy briefs, peer-reviewed publications and local/international conferences. Trial registration number NCT06046326 .
D158. Comparing Collagenase and Tissue Subcision for Cellulite Treatment of the Buttock and Thigh Regions: A Systematic Review and Meta-analysis
Raška, Otakar , Galinaud, Cécilia , Schuster, Kirsten A. , Ho, Olivia A. , TerKonda, Sarvam P. , Lin, Samuel J. , Foppiani, Jose , Stearns, Stephen, Alvarez, Angelica Hernandez , Taritsa, Iulianna C. , Lee, Bernard T.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 10, 2024 | Volume: 12 | Issue: S5 | Pages: 142-142

10.1097/01.gox.0001019216.01877.e9 Get It

The value of microvascular breast reconstruction: Cost equivalence of TRAM and DIEP flaps implications in the era of CMS reforms
Foppiani, Jose, Kim, Erin , Escobar‐Domingo, Maria J. , Taritsa, Iulianna C., Schuster, Kirsten A. , Ho, Olivia A. , Rinker, Brian, Lee, Bernard T. , Lin, Samuel J. , Foppiani, Jose , Escobar-Domingo, Maria J , Lee, Bernard T , Alvarez, Angelica Hernandez , Lee, Daniela

Mayo Clinic

Microsurgery | May 8, 2024 | Volume: 44 | Issue: 4 | Pages: No page available

10.1002/micr.31185 | PMID 38716656 Get It

AbstractBackgroundRecent CMS billing changes have raised concerns about insurance coverage for deep inferior epigastric perforator (DIEP) flap breast reconstruction. This study compared the costs and utilization of transverse rectus abdominis myocutaneous (TRAM), DIEP, and latissimus dorsi (LD) flaps in breast reconstruction.MethodThe study utilized the National Inpatient Sample database to identify female patients who underwent DIEP, TRAM, and LD flap procedures from 2016 to 2019. Key data such as patient demographics, length of stay, complications, and costs (adjusted to 2021 USD) were analyzed, focusing on differences across the flap types.ResultsA total of 17,770 weighted patient encounters were identified, with the median age being 51. The majority underwent DIEP flaps (73.5%), followed by TRAM (14.2%) and LD (12.1%) flaps. The findings revealed that DIEP and TRAM flaps had a similar length of stay (LOS), while LD flaps typically had a shorter LOS. The total hospital charges to costs using cost‐to‐charge ratio were also comparable between DIEP and TRAM flaps, whereas LD flaps were significantly less expensive. Factors such as income quartile, primary payer of hospitalization, and geographic region significantly influenced flap choice.ConclusionThe study's results appear to contradict the prevailing notion that TRAM flaps are more cost‐effective than DIEP flaps. The total hospital charges to costs using cost‐to‐charge ratio and hospital stays associated with TRAM and DIEP flaps were found to be similar. These findings suggest that changes in the insurance landscape, which may limit the use of DIEP flaps, could undermine patient autonomy while not necessarily reducing healthcare costs. Such policy shifts could favor less costly options like the LD flap, potentially altering the landscape of microvascular breast reconstruction.
OSLD nanoDot characterization for carbon radiotherapy dosimetry
Taylor, Paige A. , Hartzell, Shannon , Ciocca, Mario , Magro, Giuseppe , Alvarez, P , Peeler, C , Howell, Rebecca M. , Taylor, Paige , Mirandola, Alfredo , Peterson, Christine B. , Koay, Eugene J. , Kry, Stephen F.

Mayo Clinic

Physics in Medicine & Biology | April 25, 2024 | Volume: 69 | Issue: 11 | Pages: 115001

10.1088/1361-6560/ad43ac | PMID 38663410 Get It

Abstract Objective . This study characterized optically-stimulated luminescent dosimeter (OSLD) nanoDots for use in a therapeutic carbon beam using the Imaging and Radiation Oncology Core (IROC) framework for remote output verification. Approach . The absorbed dose correction factors for OSLD (fading, linearity, beam quality, angularity, and depletion), as defined by AAPM TG 191, were characterized for carbon beams. For the various correction factors, the effect of linear energy transfer (LET) was examined by characterizing in both a low and high LET setting. Main results . Fading was not statistically different between reference photons and carbon, nor between low and high LET beams; thus, the standard IROC-defined exponential function could be used to characterize fading. Dose linearity was characterized with a linear fit; while low and high LET carbon linearity was different, these differences were small and could be rolled into the uncertainty budget if using a single linearity correction. A linear fit between beam quality and dose-averaged LET was determined. The OSLD response at various angles of incidence was not statistically different, thus a correction factor need not be applied. There was a difference in depletion between low and high LET irradiations in a primary carbon beam, but this difference was small over the standard five readings. The largest uncertainty associated with the use of OSLDs in carbon was because of the k Q correction factor, with an uncertainty of 6.0%. The overall uncertainty budget was 6.3% for standard irradiation conditions. Significance . OSLD nanoDot response was characterized in a therapeutic carbon beam. The uncertainty was larger than for traditional photon applications. These findings enable the use of OSLDs for carbon absorbed dose measurements, but with less accuracy than conventional OSLD audit programs.
SP53. Comparing Collagenase And Tissue Subcision For Cellulite Treatment Of The Buttock And Thigh Regions: A Systematic Review And Meta-analysis
Raška, Otakar , Galinaud, Cécilia , Tarista, IIulianna C., Schuster, Kirsten A. , Ho, Olivia A. , TerKonda, Sarvam P. , Lin, Samuel J. , Foppiani, Jose , Stearns, Stephen, Alvarez, Angelica Hernandez , Lee, Bernard T.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | April 19, 2024 | Volume: 12 | Issue: S4 | Pages: 114-114

10.1097/01.gox.0001015776.61681.06 Get It

Impact of age over 70 years in the new allocation system on the outcomes of heart transplantation in the US
Gemelli, Marco , Doulamis, Ilias P. , Addonizio, Mariangela, Tzani, Aspasia , Rempakos, Athanasios, Dunque, Ernesto Ruiz, Kampaktsis, Polydoros Ν. , Guariento, Alvise , Asleh, Rabea , Álvarez, Paulino , Briasoulis, Αlexandros

Mayo Clinic

Clinical Transplantation | April 12, 2024 | Volume: 38 | Issue: 4 | Pages: No page available

10.1111/ctr.15317 | PMID 38607287 Get It

AbstractBackgroundUnited Network for Organ Sharing (UNOS) allocation criteria changed in 2018 to accommodate the increased prevalence of patients on a ventricular assist device as a bridge to heart transplant and prioritize sicker people in anticipation of a heart graft. We aimed to assess the impact of patient age in the new allocation policy on mortality following heart transplantation. Secondary outcomes included the effect of age ≥70 on post‐transplant events, including stroke, dialysis, pacemaker, and rejection requiring treatment.MethodsThe UNOS Registry was queried to identify patients who underwent heart transplants alone in the US between 2000 and 2021. Patients were divided into groups according to their age (over 70 and under 70 years old).ResultsPatients aged over 70 were more likely to require dialysis during follow‐up, but less likely to experience rejection requiring treatment, compared with patients aged <70. Age ≥70 in the new allocation system was a significant predictor of 1‐year mortality (adjusted HR: 1.41; 95% CI: 1.05–1.91; p = .024), but its effect on 5‐year mortality was not significant after adjusting for potential confounders (adjusted HR: 1.27; 95% CI:.97–1.66; p = .077). Undergoing transplantation under the new allocation policy vs the old allocation policy was not a significant predictor of mortality in patients over 70 years old.ConclusionsAge ≥70 is a significant predictor of 1‐year mortality following heart transplantation, but not at 5 and 10 years; however, the new allocation does not seem to have changed the outcomes for this group of patients.
Technical note: Radiological clinical equivalence for phantom materials in carbon ion therapy
Taylor, Paige A. , Ciocca, Mario , Hartzell, Shannon , Vai, Alessandro , Alvarez, P , Howell, Rebecca M. , Peeler, C , Taylor, Paige , Mirandola, Alfredo , Koay, Eugene J. , Peterson, Christine B. , Kry, Stephen F.

Mayo Clinic

Medical Physics | April 10, 2024 | Volume: 51 | Issue: 7 | Pages: 5154-5158

10.1002/mp.17056 | PMID 38598230 Get It

AbstractPurposeAs carbon ion radiotherapy increases in use, there are limited phantom materials for heterogeneous or anthropomorphic phantom measurements. This work characterized the radiological clinical equivalence of several phantom materials in a therapeutic carbon ion beam.MethodsEight materials were tested for radiological material‐equivalence in a carbon ion beam. The materials were computed tomography (CT)‐scanned to obtain Hounsfield unit (HU) values, then irradiated in a monoenergetic carbon ion beam to determine relative linear stopping power (RLSP). The corresponding HU and RLSP for each phantom material were compared to clinical carbon ion calibration curves. For absorbed dose comparison, ion chamber measurements were made in the center of a carbon ion spread‐out Bragg peak (SOBP) in water and in the phantom material, evaluating whether the material perturbed the absorbed dose measurement beyond what was predicted by the HU‐RLSP relationship.ResultsPolyethylene, solid water (Gammex and Sun Nuclear), Blue Water (Standard Imaging), and Techtron HPV had measured RLSP values that agreed within ±4.2% of RLSP values predicted by the clinical calibration curve. Measured RLSP for acrylic was 7.2% different from predicted. The agreement for balsa wood and cork varied between samples. Ion chamber measurements in the phantom materials were within 0.1% of ion chamber measurements in water for most materials (solid water, Blue Water, polyethylene, and acrylic), and within 1.9% for the rest of the materials (balsa wood, cork, and Techtron HPV).ConclusionsSeveral phantom materials (Blue Water, polyethylene, solid water [Gammex and Sun Nuclear], and Techtron HPV) are suitable for heterogeneous phantom measurements for carbon ion therapy. Low density materials should be carefully characterized due to inconsistencies between samples.
Evaluation of Sonicate Fluid Culture Cutoff Points for Periprosthetic Joint Infection Diagnosis
Otero, Judith Álvarez , Karau, Melissa J. , Greenwood‐Quaintance, Kerryl E. , Mandrekar, Jay , Patel, Robin , Alvarez Otero, Judith, Patel, Robin , Abdel, Matthew P.

Mayo Clinic

Open Forum Infectious Diseases | March 19, 2024 | Volume: 11 | Issue: 5 | Pages: No page available

10.1093/ofid/ofae159 | PMID 38715572 Get It

Abstract Introduction Implant sonication is useful for recovery of periprosthetic joint infection (PJI) pathogens in culture, but exact cutoff points for definition of clinically significant sonicate fluid culture results vary from study to study. The aim of this study was to define ideal sonicate fluid culture cutoff points for PJI diagnosis. Methods Sonicate fluid cultures from hip and knee prosthesis components removed between February 2007 and December 2020 were studied. Prosthesis components were placed in solid containers in the operating room; in the clinical microbiology laboratory, 400 mL Ringer's solution was added, and containers subjected to vortexing, sonication and then vortexing, followed by centrifugation. Concentrated sonicate fluid was plated on aerobic and anaerobic solid media, and culture results reported semiquantitatively, as no growth, &lt;20, 20–50, 51–100, or &gt;100 CFU/10 mL sonicate fluid. Sonicate cultures from cement spacers and cultures yielding more than 1 microorganism were excluded. Sensitivity and specificity of each cutoff point was evaluated. Results A total of 1448 sonicate fluid cultures were evaluated, 68% from knees and 32% from hips. PJI was present in 644 (44%) cases. Sensitivity of sonicate culture was 75.0% at &lt;20 CFU/10 mL, 55.3% at ≥20 CFU/10 mL, 46.9% at &gt;51 CFU/10 mL, and 39.8% at &gt;100 CFU/10 mL. Specificity was 78.2%, 99.8%, 100%, and 100%, at the 4 cutoff points, respectively. Conclusions A cutoff point for sonicate fluid culture positivity of ≥20 CFU/10 mL is suitable for PJI diagnosis.
From Case Reports to Molecular Insight: Examining the Outcomes and Underlying Mechanisms of Squamous Cell Carcinoma in Breast Implant Patients—A Systematic Review
Camicia, Alexandra, Foppiani, Jose , Raška, Otakar , Alvarez, Angelica Hernandez , Schuster, Kirsten A. , Wan, Rou , Neradová, Sylva, Lin, Gavin J., Lee, Theodore C., Lin, Samuel J. , Hernandez Alvarez, Angelica , Wan, Rou , Lee, Daniela , Taritsa, Iulianna C. , Molitor, Martin , Zikán, Michal

Mayo Clinic

International Journal of Molecular Sciences | March 1, 2024 | Volume: 25 | Issue: 5 | Pages: 2872

10.3390/ijms25052872 | PMID 38474119 Get It

There is extensive coverage in the existing literature on implant-associated lymphomas like anaplastic large-cell lymphoma, but breast implant-associated squamous cell carcinoma (BIA-SCC) has received limited scholarly attention since its first case in 1992. Thus, this study aims to conduct a qualitative synthesis focused on the underexplored association between breast implants and BIA-SCC. A systematic review was conducted utilizing the PubMed, Web of Science, and Cochrane databases to identify all currently reported cases of BIA-SCC. Additionally, a literature review was performed to identify potential biochemical mechanisms that could lead to BIA-SCC. Studies were vetted for quality using the NIH quality assessment tool. From an initial pool of 246 papers, 11 met the quality criteria for inclusion, examining a total of 14 patients aged between 40 and 81 years. BIA-SCC was found in a diverse range of implants, including those with smooth and textured surfaces, as well as those filled with saline and silicone. The condition notably manifested a proclivity for aggressive clinical progression, as evidenced by a mortality rate approximating 21.4% within a post-diagnostic interval of six months. Our literature review reveals that chronic inflammation, driven by various external factors such as pathogens and implants, can initiate carcinogenesis through epigenetic modifications and immune system alterations. This includes effects from exosomes and macrophage polarization, showcasing potential pathways for the pathogenesis of BIA-SCC. The study highlights the pressing need for further investigation into BIA-SCC, a subject hitherto inadequately addressed in the academic sphere. This necessitates the urgency for early screening and intervention to improve postoperative outcomes. While the review is confined by its reliance on case reports and series, it serves as a valuable reference for future research endeavors.
Integrating Technological Advances in Skull Base Tumor Surgical Planning: When the Past and the Present Meet with the Future
Llano, Juan P Navarro-Garcia de , González-Salido, Jimena , Ruella, Mauro , Alvarez-Caicedo, Diana C., Eagle, Carleigh R., Sánchez-Garavito, Jesús E. , Iyer, Harshvardhan , Michaelides, Loizos , Quiñones‐Hinojosa, Alfredo , Iyer, Harshvardhan G , Almeida, João Paulo

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 21, 2024 | Volume: 85 | Issue: S 01 | Pages: S1-S398

10.1055/s-0044-1780366 Get It